RxDoctor Payments Data

Ajay Sood, MD

Neurology · Elk Grove Village, ILNPI 1821220856

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $5,875 of the $6,245 with a category attached, or 94.1%. Lilly USA, LLC accounts for 73.4% of it on its own, with 4 other manufacturers making up the rest.

$6,245in general payments, 2019–2025

Across 8 payments — averaging $780.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$5K
  • Life Molecular Imaging Ltd$1K
  • Eisai Inc.$201
  • Coloplast$44
  • Genentech, Inc.$40
$986,502in research payments, 2019–2025

Across 255 payments — averaging $3868.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Genentech, Inc.$387K
  • Eli Lilly$309K
  • Eisai Inc.$290K

What the payments were for

  • Speaking & faculty fees$5,87594%
  • Food & beverage$3305%
  • Education$401%

General payments by program year

19
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,245 in reported general payments places this provider in the 75th percentile of 790 neurology providers in Illinois.

See all neurology providers in Illinois

Medicare billing

Part B allowed, 2024
$53,200
Medicare patients
163
Services billed
378

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Memantine Hcl12$625

Paid to pharmacies, not to this prescriber.

Other neurology in Elk Grove Village

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →